← FDA DRUG APPROVALS

FDA ANDA · ANDA085321

CAM-METRAZINE

Sponsor: CHARTWELL RX

APPLICATION
ANDA085321
TYPE
ANDA
ORIGINAL APPROVAL
1977-01-18
LATEST ACTION
2000-10-06
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

CAM-METRAZINEDiscontinued
PHENDIMETRAZINE TARTRATE 35MG · TABLET · ORAL

Approval history

2000-10-06Manufacturing (CMC) · Supplement 59AP
1991-08-20Labeling · Supplement 54AP
1989-12-13Labeling · Supplement 53AP
1988-10-24Manufacturing (CMC) · Supplement 51AP
1988-10-24Manufacturing (CMC) · Supplement 43AP
1988-06-27Manufacturing (CMC) · Supplement 50AP
1984-06-07Manufacturing (CMC) · Supplement 46AP
1984-04-18Manufacturing (CMC) · Supplement 45AP
1984-04-18Manufacturing (CMC) · Supplement 44AP
1983-06-09Manufacturing (CMC) · Supplement 42AP
1983-06-06Manufacturing (CMC) · Supplement 39AP
1983-06-06Manufacturing (CMC) · Supplement 38AP
1983-06-06Manufacturing (CMC) · Supplement 40AP
1977-01-18OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →